BTK is one of the major regulators of proliferation and cell survival in MCL and can be inhibited in the BCR pathway by ibrutinib, which down-regulates both phospho-STAT3 (pSTAT3) and NF-κB [150]. The gene discussed is STAT3; the disease is mantle cell lymphoma.